Search Within

Advanced Practice Providers

  1. "David Chung"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (7)
Groups
  1. Bone Marrow Transplant (29)
  2. Center for Hematologic Malignancies (29)
  3. Department of Medicine (29)
  4. Hematologic Malignancies, Division of (29)
  5. Survivorship Research (29)
  6. CTCR Scholars (23)

More Groups

People
  1. David Chung (29)
  2. Sergio Giralt (25)
  3. Heather Landau (24)
  4. Gunjan Shah (22)
  5. Sean Devlin (18)
  6. Michael Scordo (15)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Blood (15)
  2. Biology of Blood and Marrow Transplantation (4)
  3. Clinical Lymphoma, Myeloma and Leukemia (2)
  4. Transplantation and Cellular Therapy (2)
  5. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (1)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Elsevier Inc. (8)
  3. American Association for Cancer Research (1)
  4. American Medical Association (1)
  5. American Society for Microbiology (1)
  6. Nature Publishing Group (1)

More Publishers

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Manufacture of anti-BCMA CAR T cell is feasible after salvage autologous or allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Perica, K.; Nagel, K.; Payson, E.; Hosszu, K. K.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies
    Journal Article

    Howard, A. J.; Concepcion, I.; Wang, A. X.; Hamadeh, I. S.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Korde, N.; Lesokhin, A. M.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Low target antigen expression mediates resistance to BCMA CAR T cell therapy
    Meeting Abstract

    Perica, K.; Nataraj, S.; Sjojstrand, M. L.; Nagel, K.; Pavkovic, E.; Payson, E.; Cuenca, A.; Patel, A.; Chung, D.; Mailankody, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ghosh, A.; Nagel, K.; Hosszu, K.; Datta, A.; Thompson, C.; Levia, K.; Kamrowski, A.; McAvoy, D.; Chung, D.; Landau, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Pilot trial of homebound hematopoietic cell transplantation
    Journal Article

    Landau, H. J.; Orlando, E.; Rodriguez, E. S.; Applebaum, A.; Mitchell, H. R.; Peled, J. U.; Khan, N.; Funnell, T.; Chung, D.; Scordo, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Adintori, P. A.; Knezevic, A.; Devlin, S. M.; Buchan, M. L.; Preston, E. V.; Lin, A. P.; Rodriguez, N. T.; Carino, C. A.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Humoral response to COVID-19 vaccination given pre-cellular therapy wanes in patients after cellular therapy: An argument for full reimmunization
    Meeting Abstract

    Shah, G. L.; Chung, D. J.; Tamari, R.; Politikos, I.; Jakubowski, A. A.; Marcello, L.; Doddi, S.; Ramanathan, L.; Pessin, M.; Palazzo, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant
    Journal Article

    Sola, M.; Bhatt, V.; Palazzo, M.; Cavalier, K. E.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D.; Dahi, P. B.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Timing and immune status after cellular therapies predict response to COVID-19 vaccines
    Meeting Abstract

    Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save